港股异动 | CRO概念股转跌药明康德(02359)一度跌超9% 美国BIO称将剔除药明康德会员资格

智通财经03-14

智通财经APP获悉，CRO概念股下挫，药明系领跌。截至发稿，药明康德(02359)跌8.7%，报46.7港元；金斯瑞生物科技(01548)跌1.85%，报16.96港元。凯莱英(06821)跌1%，报74.15港元。消息面上，据报道，3月13日晚间，总部位于美国华盛顿的贸易协会BIO（美国生物技术创新组织）宣布将剔除WuXi（药明康德）会员资格，并将终止与其合作。在新闻稿中，Bio表示，它将...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2419328616?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2024-03-14 10:53","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2419328616","market":"sh","top_or_hot":-1,"title":"港股异动 | CRO概念股转跌 药明康德(02359)一度跌超9% 美国BIO称将剔除药明康德会员资格","media":"智通财经","content":"<div>\n<p>智通财经APP获悉，CRO概念股下挫，药明系领跌。截至发稿，药明康德(02359)跌8.7%，报46.7港元；金斯瑞生物科技(01548)跌1.85%，报16.96港元。凯莱英(06821)跌1%，报74.15港元。消息面上，据报道，3月13日晚间，总部位于美国华盛顿的贸易协会BIO（美国生物技术创新组织）宣布将剔除WuXi（药明康德）会员资格，并将终止与其合作。在新闻稿中，Bio表示，它将...</p>\n\n<a href=\"http://www.zhitongcaijing.com/content/detail/1086274.html\">网页链接</a>\n\n</div>\n","source":"stock_zhitongcaijing","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>港股异动 | CRO概念股转跌 药明康德(02359)一度跌超9% 美国BIO称将剔除药明康德会员资格</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n港股异动 | CRO概念股转跌 药明康德(02359)一度跌超9% 美国BIO称将剔除药明康德会员资格\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-03-14 10:53 北京时间&nbsp;&nbsp;&nbsp;<a href=http://www.zhitongcaijing.com/content/detail/1086274.html><strong>智通财经</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>智通财经APP获悉，CRO概念股下挫，药明系领跌。截至发稿，药明康德(02359)跌8.7%，报46.7港元；金斯瑞生物科技(01548)跌1.85%，报16.96港元。凯莱英(06821)跌1%，报74.15港元。消息面上，据报道，3月13日晚间，总部位于美国华盛顿的贸易协会BIO（美国生物技术创新组织）宣布将剔除WuXi（药明康德）会员资格，并将终止与其合作。在新闻稿中，Bio表示，它将...</p>\n\n<a href=\"http://www.zhitongcaijing.com/content/detail/1086274.html\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4588","symbol_name":"碎股","start_time":0,"source_url":"http://www.zhitongcaijing.com/content/detail/1086274.html","article_id":"2419328616","we_media_id":null,"thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2419328616","pubTimestamp":1710384791,"sourceInfo":{"source_id":"stock_zhitongcaijing","name":"智通财经网"},"weMediaInfo":null,"summary":"智通财经APP获悉，CRO概念股下挫，药明系领跌。截至发稿，药明康德(02359)跌8.7%，报46.7港元；金斯瑞生物科技(01548)跌1.85%，报16.96港元。凯莱英(06821)跌1%，报74.15港元。消息面上，据报道，3月13日晚间，总部位于美国华盛顿的贸易协会BIO（美国生物技术创新组织）宣布将剔除WuXi（药明康德）会员资格，并将终止与其合作。在新闻稿中，Bio表示，它将采取措施“将剔除药明康德会员资格”，并全力支持美国《生物安全法案》。并且，该法案可能会禁止药明康德和其它几家中国医疗保健公司在美国开展业务，或与美国公司合作。","collect":0,"end_time":0,"defaultTopTitle":"zhitongcaijing.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"BK4588":"碎股","07226":"XL二南方恒科","LU0320764599.SGD":"FTIF - Templeton China A Acc SGD","LU2045819591.USD":"Natixis WCM Global Emerging Markets Equity R/A USD","LU2242644610.SGD":"Fidelity China Innovation A-ACC-SGD","LU0708995583.HKD":"TEMPLETON CHINA \"A\" (HKD) ACC","BK1141":"生命科学工具和服务","BK1191":"制药","LU0052750758.USD":"富兰克林中国基金A Acc","YINN":"三倍做多富时中国ETF-Direxion","BIO":"Bio Rad实验室","LU2125910500.SGD":"Natixis WCM Global Emerging Markets Equity H-R/A SGD","BK1576":"医药外包概念","BK4585":"ETF&股票定投概念","06821":"凯莱英","01548":"金斯瑞生物科技","BK1583":"高瓴概念","LU1046422090.SGD":"Fidelity Pacific A-SGD","YANG":"三倍做空富时中国ETF-Direxion","BK4121":"生命科学工具和服务","02359":"药明康德"},"translate_title":"Hong Kong stocks changed CRO concept stocks turned down. WuXi PharmaTech (02359) once fell more than 9%. The US BIO said that it would eliminate WuXi PharmaTech membership","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"02359":1,"YINN":1,"YANG":1,"BIO":1,"07226":1,"01548":0.9,"06821":0.9},"content_text":"智通财经APP获悉，CRO概念股下挫，药明系领跌。截至发稿，药明康德(02359)跌8.7%，报46.7港元；金斯瑞生物科技(01548)跌1.85%，报16.96港元。凯莱英(06821)跌1%，报74.15港元。消息面上，据报道，3月13日晚间，总部位于美国华盛顿的贸易协会BIO（美国生物技术创新组织）宣布将剔除WuXi（药明康德）会员资格，并将终止与其合作。在新闻稿中，Bio表示，它将采取措施“将剔除药明康德会员资格”，并全力支持美国《生物安全法案》。并且，该法案可能会禁止药明康德和其它几家中国医疗保健公司在美国开展业务，或与美国公司合作。","kind":null,"is_publish_news":null,"is_publish_highlight":null,"is_publish_live":null,"is_publish_wemedia":null,"editions":null,"symbols":[],"gpt_button":0},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.22.4","shortVersion":"4.22.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2419328616"}

港股异动 | CRO概念股转跌 药明康德(02359)一度跌超9% 美国BIO称将剔除药明康德会员资格

精彩评论

港股异动 | CRO概念股转跌药明康德(02359)一度跌超9% 美国BIO称将剔除药明康德会员资格